世界のアンドロゲン遮断療法（ADT）市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Androgen Deprivation Therapy (ADT) Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A13974
• 出版社/出版日：GlobalInfoResearch / 2021年7月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、108ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料では、アンドロゲン遮断療法（ADT）のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。アンドロゲン遮断療法（ADT）の種類別市場規模（医療、外科、その他）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・アンドロゲン遮断療法（ADT）の市場概要
・企業情報（企業概要、製品概要、販売量、価格、売上）：Pfizer、Astellas Pharma、Johnson & Johnson、Novartis International、Merck、Veru、Sanofi、GlaxoSmithKline、Bayer、Orion、AstraZeneca
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年：医療、外科、その他
・用途別分析2016年-2026年：病院、クリニック、その他
・アンドロゲン遮断療法（ADT）の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ
・アンドロゲン遮断療法（ADT）のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア
・アンドロゲン遮断療法（ADT）のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア
・アンドロゲン遮断療法（ADT）の南米市場規模2016年-2026年：ブラジル、アルゼンチン
・アンドロゲン遮断療法（ADT）の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Androgen Deprivation Therapy (ADT) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Androgen Deprivation Therapy (ADT) size is estimated to be USD 7161.5 million in 2026 from USD 5940.3 million in 2020, with a change XX% between 2020 and 2021. The global Androgen Deprivation Therapy (ADT) market size is expected to grow at a CAGR of 4.8% for the next five years.

Market segmentation
Androgen Deprivation Therapy (ADT) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Medicine
Surgery
Other

Market segment by Application, can be divided into
Hospital
Clinic
Other

Market segment by players, this report covers
Pfizer
Astellas Pharma
Johnson & Johnson
Novartis International
Merck
Veru
Sanofi
GlaxoSmithKline
Bayer
Orion
AstraZeneca

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Androgen Deprivation Therapy (ADT)
1.2 Classification of Androgen Deprivation Therapy (ADT) by Type
1.2.1 Overview: Global Androgen Deprivation Therapy (ADT) Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Type in 2020
1.2.3 Medicine
1.2.4 Surgery
1.2.5 Other
1.3 Global Androgen Deprivation Therapy (ADT) Market by Application
1.3.1 Overview: Global Androgen Deprivation Therapy (ADT) Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Androgen Deprivation Therapy (ADT) Market Size & Forecast
1.5 Global Androgen Deprivation Therapy (ADT) Market Size and Forecast by Region
1.5.1 Global Androgen Deprivation Therapy (ADT) Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Androgen Deprivation Therapy (ADT) Market Size by Region, (2016-2021)
1.5.3 North America Androgen Deprivation Therapy (ADT) Market Size and Prospect (2016-2026)
1.5.4 Europe Androgen Deprivation Therapy (ADT) Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size and Prospect (2016-2026)
1.5.6 South America Androgen Deprivation Therapy (ADT) Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Androgen Deprivation Therapy (ADT) Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Androgen Deprivation Therapy (ADT) Market Drivers
1.6.2 Androgen Deprivation Therapy (ADT) Market Restraints
1.6.3 Androgen Deprivation Therapy (ADT) Trends Analysis
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Androgen Deprivation Therapy (ADT) Product and Solutions
2.1.4 Pfizer Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 Astellas Pharma
2.2.1 Astellas Pharma Details
2.2.2 Astellas Pharma Major Business
2.2.3 Astellas Pharma Androgen Deprivation Therapy (ADT) Product and Solutions
2.2.4 Astellas Pharma Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Astellas Pharma Recent Developments and Future Plans
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Androgen Deprivation Therapy (ADT) Product and Solutions
2.3.4 Johnson & Johnson Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Johnson & Johnson Recent Developments and Future Plans
2.4 Novartis International
2.4.1 Novartis International Details
2.4.2 Novartis International Major Business
2.4.3 Novartis International Androgen Deprivation Therapy (ADT) Product and Solutions
2.4.4 Novartis International Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Novartis International Recent Developments and Future Plans
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business
2.5.3 Merck Androgen Deprivation Therapy (ADT) Product and Solutions
2.5.4 Merck Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Merck Recent Developments and Future Plans
2.6 Veru
2.6.1 Veru Details
2.6.2 Veru Major Business
2.6.3 Veru Androgen Deprivation Therapy (ADT) Product and Solutions
2.6.4 Veru Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Veru Recent Developments and Future Plans
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Androgen Deprivation Therapy (ADT) Product and Solutions
2.7.4 Sanofi Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Sanofi Recent Developments and Future Plans
2.8 GlaxoSmithKline
2.8.1 GlaxoSmithKline Details
2.8.2 GlaxoSmithKline Major Business
2.8.3 GlaxoSmithKline Androgen Deprivation Therapy (ADT) Product and Solutions
2.8.4 GlaxoSmithKline Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 GlaxoSmithKline Recent Developments and Future Plans
2.9 Bayer
2.9.1 Bayer Details
2.9.2 Bayer Major Business
2.9.3 Bayer Androgen Deprivation Therapy (ADT) Product and Solutions
2.9.4 Bayer Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Bayer Recent Developments and Future Plans
2.10 Orion
2.10.1 Orion Details
2.10.2 Orion Major Business
2.10.3 Orion Androgen Deprivation Therapy (ADT) Product and Solutions
2.10.4 Orion Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Orion Recent Developments and Future Plans
2.11 AstraZeneca
2.11.1 AstraZeneca Details
2.11.2 AstraZeneca Major Business
2.11.3 AstraZeneca Androgen Deprivation Therapy (ADT) Product and Solutions
2.11.4 AstraZeneca Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 AstraZeneca Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Androgen Deprivation Therapy (ADT) Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Androgen Deprivation Therapy (ADT) Players Market Share
3.2.2 Top 10 Androgen Deprivation Therapy (ADT) Players Market Share
3.2.3 Market Competition Trend
3.3 Androgen Deprivation Therapy (ADT) Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Androgen Deprivation Therapy (ADT) Revenue and Market Share by Type (2016-2021)
4.2 Global Androgen Deprivation Therapy (ADT) Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Application (2016-2021)
5.2 Androgen Deprivation Therapy (ADT) Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Androgen Deprivation Therapy (ADT) Revenue by Type (2016-2026)
6.2 North America Androgen Deprivation Therapy (ADT) Revenue by Application (2016-2026)
6.3 North America Androgen Deprivation Therapy (ADT) Market Size by Country
6.3.1 North America Androgen Deprivation Therapy (ADT) Revenue by Country (2016-2026)
6.3.2 United States Androgen Deprivation Therapy (ADT) Market Size and Forecast (2016-2026)
6.3.3 Canada Androgen Deprivation Therapy (ADT) Market Size and Forecast (2016-2026)
6.3.4 Mexico Androgen Deprivation Therapy (ADT) Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Androgen Deprivation Therapy (ADT) Revenue by Type (2016-2026)
7.2 Europe Androgen Deprivation Therapy (ADT) Revenue by Application (2016-2026)
7.3 Europe Androgen Deprivation Therapy (ADT) Market Size by Country
7.3.1 Europe Androgen Deprivation Therapy (ADT) Revenue by Country (2016-2026)
7.3.2 Germany Androgen Deprivation Therapy (ADT) Market Size and Forecast (2016-2026)
7.3.3 France Androgen Deprivation Therapy (ADT) Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Androgen Deprivation Therapy (ADT) Market Size and Forecast (2016-2026)
7.3.5 Russia Androgen Deprivation Therapy (ADT) Market Size and Forecast (2016-2026)
7.3.6 Italy Androgen Deprivation Therapy (ADT) Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Androgen Deprivation Therapy (ADT) Revenue by Type (2016-2026)
8.2 Asia-Pacific Androgen Deprivation Therapy (ADT) Revenue by Application (2016-2026)
8.3 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region
8.3.1 Asia-Pacific Androgen Deprivation Therapy (ADT) Revenue by Region (2016-2026)
8.3.2 China Androgen Deprivation Therapy (ADT) Market Size and Forecast (2016-2026)
8.3.3 Japan Androgen Deprivation Therapy (ADT) Market Size and Forecast (2016-2026)
8.3.4 South Korea Androgen Deprivation Therapy (ADT) Market Size and Forecast (2016-2026)
8.3.5 India Androgen Deprivation Therapy (ADT) Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Androgen Deprivation Therapy (ADT) Market Size and Forecast (2016-2026)
8.3.7 Australia Androgen Deprivation Therapy (ADT) Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Androgen Deprivation Therapy (ADT) Revenue by Type (2016-2026)
9.2 South America Androgen Deprivation Therapy (ADT) Revenue by Application (2016-2026)
9.3 South America Androgen Deprivation Therapy (ADT) Market Size by Country
9.3.1 South America Androgen Deprivation Therapy (ADT) Revenue by Country (2016-2026)
9.3.2 Brazil Androgen Deprivation Therapy (ADT) Market Size and Forecast (2016-2026)
9.3.3 Argentina Androgen Deprivation Therapy (ADT) Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Androgen Deprivation Therapy (ADT) Revenue by Type (2016-2026)
10.2 Middle East & Africa Androgen Deprivation Therapy (ADT) Revenue by Application (2016-2026)
10.3 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country
10.3.1 Middle East & Africa Androgen Deprivation Therapy (ADT) Revenue by Country (2016-2026)
10.3.2 Turkey Androgen Deprivation Therapy (ADT) Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Androgen Deprivation Therapy (ADT) Market Size and Forecast (2016-2026)
10.3.4 UAE Androgen Deprivation Therapy (ADT) Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Androgen Deprivation Therapy (ADT) Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Androgen Deprivation Therapy (ADT) Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Androgen Deprivation Therapy (ADT) Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Androgen Deprivation Therapy (ADT) Revenue (USD Million) by Region (2016-2021)
Table 5. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Region (2021-2026)
Table 6. Pfizer Corporate Information, Head Office, and Major Competitors
Table 7. Pfizer Major Business
Table 8. Pfizer Androgen Deprivation Therapy (ADT) Product and Solutions
Table 9. Pfizer Androgen Deprivation Therapy (ADT) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Astellas Pharma Corporate Information, Head Office, and Major Competitors
Table 11. Astellas Pharma Major Business
Table 12. Astellas Pharma Androgen Deprivation Therapy (ADT) Product and Solutions
Table 13. Astellas Pharma Androgen Deprivation Therapy (ADT) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 15. Johnson & Johnson Major Business
Table 16. Johnson & Johnson Androgen Deprivation Therapy (ADT) Product and Solutions
Table 17. Johnson & Johnson Androgen Deprivation Therapy (ADT) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Novartis International Corporate Information, Head Office, and Major Competitors
Table 19. Novartis International Major Business
Table 20. Novartis International Androgen Deprivation Therapy (ADT) Product and Solutions
Table 21. Novartis International Androgen Deprivation Therapy (ADT) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Merck Corporate Information, Head Office, and Major Competitors
Table 23. Merck Major Business
Table 24. Merck Androgen Deprivation Therapy (ADT) Product and Solutions
Table 25. Merck Androgen Deprivation Therapy (ADT) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Veru Corporate Information, Head Office, and Major Competitors
Table 27. Veru Major Business
Table 28. Veru Androgen Deprivation Therapy (ADT) Product and Solutions
Table 29. Veru Androgen Deprivation Therapy (ADT) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Sanofi Corporate Information, Head Office, and Major Competitors
Table 31. Sanofi Major Business
Table 32. Sanofi Androgen Deprivation Therapy (ADT) Product and Solutions
Table 33. Sanofi Androgen Deprivation Therapy (ADT) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 35. GlaxoSmithKline Major Business
Table 36. GlaxoSmithKline Androgen Deprivation Therapy (ADT) Product and Solutions
Table 37. GlaxoSmithKline Androgen Deprivation Therapy (ADT) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Bayer Corporate Information, Head Office, and Major Competitors
Table 39. Bayer Major Business
Table 40. Bayer Androgen Deprivation Therapy (ADT) Product and Solutions
Table 41. Bayer Androgen Deprivation Therapy (ADT) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Orion Corporate Information, Head Office, and Major Competitors
Table 43. Orion Major Business
Table 44. Orion Androgen Deprivation Therapy (ADT) Product and Solutions
Table 45. Orion Androgen Deprivation Therapy (ADT) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 47. AstraZeneca Major Business
Table 48. AstraZeneca Androgen Deprivation Therapy (ADT) Product and Solutions
Table 49. AstraZeneca Androgen Deprivation Therapy (ADT) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Global Androgen Deprivation Therapy (ADT) Revenue (USD Million) by Players (2019-2021)
Table 51. Global Androgen Deprivation Therapy (ADT) Revenue Share by Players (2019-2021)
Table 52. Breakdown of Androgen Deprivation Therapy (ADT) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 53. Androgen Deprivation Therapy (ADT) Players Head Office, Products and Services Provided
Table 54. Androgen Deprivation Therapy (ADT) Mergers & Acquisitions in the Past Five Years
Table 55. Androgen Deprivation Therapy (ADT) New Entrants and Expansion Plans
Table 56. Global Androgen Deprivation Therapy (ADT) Revenue (USD Million) by Type (2016-2021)
Table 57. Global Androgen Deprivation Therapy (ADT) Revenue Share by Type (2016-2021)
Table 58. Global Androgen Deprivation Therapy (ADT) Revenue Forecast by Type (2021-2026)
Table 59. Global Androgen Deprivation Therapy (ADT) Revenue by Application (2016-2021)
Table 60. Global Androgen Deprivation Therapy (ADT) Revenue Forecast by Application (2021-2026)
Table 61. North America Androgen Deprivation Therapy (ADT) Revenue by Type (2016-2021) & (USD Million)
Table 62. North America Androgen Deprivation Therapy (ADT) Revenue by Type (2021-2026) & (USD Million)
Table 63. North America Androgen Deprivation Therapy (ADT) Revenue by Application (2016-2021) & (USD Million)
Table 64. North America Androgen Deprivation Therapy (ADT) Revenue by Application (2021-2026) & (USD Million)
Table 65. North America Androgen Deprivation Therapy (ADT) Revenue by Country (2016-2021) & (USD Million)
Table 66. North America Androgen Deprivation Therapy (ADT) Revenue by Country (2021-2026) & (USD Million)
Table 67. Europe Androgen Deprivation Therapy (ADT) Revenue by Type (2016-2021) & (USD Million)
Table 68. Europe Androgen Deprivation Therapy (ADT) Revenue by Type (2021-2026) & (USD Million)
Table 69. Europe Androgen Deprivation Therapy (ADT) Revenue by Application (2016-2021) & (USD Million)
Table 70. Europe Androgen Deprivation Therapy (ADT) Revenue by Application (2021-2026) & (USD Million)
Table 71. Europe Androgen Deprivation Therapy (ADT) Revenue by Country (2016-2021) & (USD Million)
Table 72. Europe Androgen Deprivation Therapy (ADT) Revenue by Country (2021-2026) & (USD Million)
Table 73. Asia-Pacific Androgen Deprivation Therapy (ADT) Revenue by Type (2016-2021) & (USD Million)
Table 74. Asia-Pacific Androgen Deprivation Therapy (ADT) Revenue by Type (2021-2026) & (USD Million)
Table 75. Asia-Pacific Androgen Deprivation Therapy (ADT) Revenue by Application (2016-2021) & (USD Million)
Table 76. Asia-Pacific Androgen Deprivation Therapy (ADT) Revenue by Application (2021-2026) & (USD Million)
Table 77. Asia-Pacific Androgen Deprivation Therapy (ADT) Revenue by Region (2016-2021) & (USD Million)
Table 78. Asia-Pacific Androgen Deprivation Therapy (ADT) Revenue by Region (2021-2026) & (USD Million)
Table 79. South America Androgen Deprivation Therapy (ADT) Revenue by Type (2016-2021) & (USD Million)
Table 80. South America Androgen Deprivation Therapy (ADT) Revenue by Type (2021-2026) & (USD Million)
Table 81. South America Androgen Deprivation Therapy (ADT) Revenue by Application (2016-2021) & (USD Million)
Table 82. South America Androgen Deprivation Therapy (ADT) Revenue by Application (2021-2026) & (USD Million)
Table 83. South America Androgen Deprivation Therapy (ADT) Revenue by Country (2016-2021) & (USD Million)
Table 84. South America Androgen Deprivation Therapy (ADT) Revenue by Country (2021-2026) & (USD Million)
Table 85. Middle East & Africa Androgen Deprivation Therapy (ADT) Revenue by Type (2016-2021) & (USD Million)
Table 86. Middle East & Africa Androgen Deprivation Therapy (ADT) Revenue by Type (2021-2026) & (USD Million)
Table 87. Middle East & Africa Androgen Deprivation Therapy (ADT) Revenue by Application (2016-2021) & (USD Million)
Table 88. Middle East & Africa Androgen Deprivation Therapy (ADT) Revenue by Application (2021-2026) & (USD Million)
Table 89. Middle East & Africa Androgen Deprivation Therapy (ADT) Revenue by Country (2016-2021) & (USD Million)
Table 90. Middle East & Africa Androgen Deprivation Therapy (ADT) Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Androgen Deprivation Therapy (ADT) Picture
Figure 2. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Type in 2020
Figure 3. Medicine
Figure 4. Surgery
Figure 5. Other
Figure 6. Androgen Deprivation Therapy (ADT) Revenue Market Share by Application in 2020
Figure 7. Hospital Picture
Figure 8. Clinic Picture
Figure 9. Other Picture
Figure 10. Global Androgen Deprivation Therapy (ADT) Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Androgen Deprivation Therapy (ADT) Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Region (2016-2026)
Figure 13. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Region in 2020
Figure 14. North America Androgen Deprivation Therapy (ADT) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Androgen Deprivation Therapy (ADT) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Androgen Deprivation Therapy (ADT) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Androgen Deprivation Therapy (ADT) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Androgen Deprivation Therapy (ADT) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Androgen Deprivation Therapy (ADT) Market Drivers
Figure 20. Androgen Deprivation Therapy (ADT) Market Restraints
Figure 21. Androgen Deprivation Therapy (ADT) Market Trends
Figure 22. Pfizer Recent Developments and Future Plans
Figure 23. Astellas Pharma Recent Developments and Future Plans
Figure 24. Johnson & Johnson Recent Developments and Future Plans
Figure 25. Novartis International Recent Developments and Future Plans
Figure 26. Merck Recent Developments and Future Plans
Figure 27. Veru Recent Developments and Future Plans
Figure 28. Sanofi Recent Developments and Future Plans
Figure 29. GlaxoSmithKline Recent Developments and Future Plans
Figure 30. Bayer Recent Developments and Future Plans
Figure 31. Orion Recent Developments and Future Plans
Figure 32. AstraZeneca Recent Developments and Future Plans
Figure 33. Global Androgen Deprivation Therapy (ADT) Revenue Share by Players in 2020
Figure 34. Androgen Deprivation Therapy (ADT) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players Androgen Deprivation Therapy (ADT) Revenue Market Share in 2020
Figure 36. Global Top 10 Players Androgen Deprivation Therapy (ADT) Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global Androgen Deprivation Therapy (ADT) Revenue Share by Type in 2020
Figure 39. Global Androgen Deprivation Therapy (ADT) Market Share Forecast by Type (2021-2026)
Figure 40. Global Androgen Deprivation Therapy (ADT) Revenue Share by Application in 2020
Figure 41. Global Androgen Deprivation Therapy (ADT) Market Share Forecast by Application (2021-2026)
Figure 42. North America Androgen Deprivation Therapy (ADT) Sales Market Share by Type (2016-2026)
Figure 43. North America Androgen Deprivation Therapy (ADT) Sales Market Share by Application (2016-2026)
Figure 44. North America Androgen Deprivation Therapy (ADT) Revenue Market Share by Country (2016-2026)
Figure 45. United States Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Androgen Deprivation Therapy (ADT) Sales Market Share by Type (2016-2026)
Figure 49. Europe Androgen Deprivation Therapy (ADT) Sales Market Share by Application (2016-2026)
Figure 50. Europe Androgen Deprivation Therapy (ADT) Revenue Market Share by Country (2016-2026)
Figure 51. Germany Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Androgen Deprivation Therapy (ADT) Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific Androgen Deprivation Therapy (ADT) Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Androgen Deprivation Therapy (ADT) Revenue Market Share by Region (2016-2026)
Figure 59. China Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Androgen Deprivation Therapy (ADT) Sales Market Share by Type (2016-2026)
Figure 66. South America Androgen Deprivation Therapy (ADT) Sales Market Share by Application (2016-2026)
Figure 67. South America Androgen Deprivation Therapy (ADT) Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa Androgen Deprivation Therapy (ADT) Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa Androgen Deprivation Therapy (ADT) Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa Androgen Deprivation Therapy (ADT) Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source

以下、関連資料のご紹介

世界のがんホルモン療法剤市場 2021：企業別、地域別、種類・用途別

Global Cancer Hormone Therapy Drugs Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-107A12131 2021年7月 108Pages
当調査資料では、がんホルモン療法剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。がんホルモン療法剤の種類別市場規模（タモキシフェン、アロマターゼ阻害剤、抗アンドロゲン、アンドロゲン合成阻害剤、その他）、用途別市場規模（乳がん、前立腺がん）、地域別市場...

世界の陽子線治療市場 2021：企業別、地域別、種類・用途別

Global Proton Therapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-107A14080 2021年7月 85Pages
当調査資料では、陽子線治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。陽子線治療の種類別市場規模（シンクロトロン、サイクロトロン、シンクロサイクロトロン、線形加速器）、用途別市場規模（病院、陽子線治療センター）、地域別市場規模（北米、アメリカ、ヨー...

世界の補助療法市場 2021：企業別、地域別、種類・用途別

Global Adjuvant Therapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-107A12026 2021年7月 103Pages
当調査資料では、補助療法のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。補助療法の種類別市場規模（化学療法、放射線療法、ホルモン療法、その他）、用途別市場規模（病院、医療機関、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東...

世界の長寿・老化防止療法市場 2021：企業別、地域別、種類・用途別

Global Longevity and Anti-senescence Therapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-107A12435 2021年7月 104Pages
当調査資料では、長寿・老化防止療法のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。長寿・老化防止療法の種類別市場規模（溶血性薬物療法、遺伝子治療、免疫療法、その他幹細胞治療）、用途別市場規模（病院、医療機関、医薬品・機器販売）、地域別市場規模（北米、ア...

世界のTILセラピー市場 2021：企業別、地域別、種類・用途別

Global TIL Therapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-107A11953 2021年7月 86Pages
当調査資料では、TILセラピーのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。TILセラピーの種類別市場規模（シングル注射、マルチ注射）、用途別市場規模（胃がん、膵臓がん、肝細胞がん、子宮内膜がん、子宮頸がん、尿道がん、腎細胞がん、その他）、地域別市場...

世界の中枢神経系疾患用遺伝子治療市場 2021：企業別、地域別、種類・用途別

Global Gene Therapy for CNS Disorders Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-107A12290 2021年7月 104Pages
当調査資料では、中枢神経系疾患用遺伝子治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。中枢神経系疾患用遺伝子治療の種類別市場規模（Ex Vivo、 In Vivo）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロ...

世界の筋骨格系障害幹細胞治療市場 2021：企業別、地域別、種類・用途別

Global Musculoskeletal Disorder Stem Cell Therapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-107A15035 2021年7月 106Pages
当調査資料では、筋骨格系障害幹細胞治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。筋骨格系障害幹細胞治療の種類別市場規模（同種異系、自家）、用途別市場規模（筋疾患、骨格筋疾患）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南ア...

世界の陽子線治療ソリューション市場 2021：企業別、地域別、種類・用途別

Global Proton Therapy Solutions Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-107A12629 2021年7月 101Pages
当調査資料では、陽子線治療ソリューションのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。陽子線治療ソリューションの種類別市場規模（シングルルーム陽子線治療ソリューション、マルチルーム陽子線治療ソリューション）、用途別市場規模（病院、陽子線治療センター、...

世界の遺伝子治療製品市場 2021：企業別、地域別、種類・用途別

Global Gene Therapy Products Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-107A14574 2021年7月 88Pages
当調査資料では、遺伝子治療製品のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。遺伝子治療製品の種類別市場規模（エクスビボ、インビボ）、用途別市場規模（がん、単発性、感染症、心血管疾患、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、...

世界の季節性情動障害用光線療法市場 2021：企業別、地域別、種類・用途別

Global Seasonal Affective Disorder Light Therapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-107A12686 2021年7月 108Pages
当調査資料では、季節性情動障害用光線療法のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。季節性情動障害用光線療法の種類別市場規模（光線療法ランプ、光線療法目覚まし時計）、用途別市場規模（病院、クリニック、医学研究センター、その他）、地域別市場規模（北米...

世界のがんホルモン療法薬市場予測（～2024年） Hormone Therapy, (also called hormonal therapy, hormone treatment, or endocrine therapy) is a cancer treatment that blocks or lowers the growth of cancer that uses hormones to grow. Doctors use it to treat some cancers such as breast and prostate cancer. Scope of the Report: The global Cancer Hormon…
世界のがんホルモン療法剤市場 2021：企業別、地域別、種類・用途別 The Cancer Hormone Therapy Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
世界の陽子線治療市場 2021：企業別、地域別、種類・用途別 The Proton Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rec…
世界の補助療法市場 2021：企業別、地域別、種類・用途別 The Adjuvant Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…
世界の長寿・老化防止療法市場 2021：企業別、地域別、種類・用途別 The Longevity and Anti-senescence Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…